Azstarys and Qelbree Will Be the Latest Meds for ADHD

September 2021

You'll see new meds for ADHD hitting your pharmacy shelves.

Azstarys combines immediate-release dexmethylphenidate with SERdexmethylphenidate...and is a once-daily Schedule II stimulant.

It's touted to control symptoms throughout the day...since dexmethylphenidate works quickly and serdexmethylphenidate kicks in later.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Biosimilars Watch For Semglee to Be "Interchangeable" With Lantus
ADHD Azstarys and Qelbree Will Be the Latest Meds for ADHD
COVID-19 Identify Patients Who May Qualify for Meds to Prevent COVID-19 After Exposure
OTC Products Point Out Surprising Ingredients in New Aleve Topicals
Vaginal Infections Know What to Watch for When Dispensing Brexafemme or Solosec
Statins Expect Most Pregnant Patients to Still Avoid Statins Despite Label Changes
Communication Optimize Communication With Prescriber Offices
Diabetes Gather Info to Help Guide Diabetes Med Use During a Fast
Fever Listen for Questions About Treating Fever in Children